Core Insights - The consumer discretionary sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Company Summaries - **Gentex Corp (NASDAQ:GNTX)**: Reported third-quarter EPS and sales below expectations, with North American OEM revenue increasing approximately 5% quarter-over-quarter. The stock fell around 16% over the past month, with a 52-week low of $20.28. RSI Value is 29.8, and shares closed at $23.72 [8] - **Cracker Barrel Old Country Store Inc (NASDAQ:CBRL)**: Received an Equal-Weight rating from Wells Fargo with a price target of $42. The stock fell around 21% over the past month, with a 52-week low of $33.86. RSI Value is 23.7, and shares closed at $35.56 [8] - **O'Reilly Automotive Inc (NASDAQ:ORLY)**: Reported strong quarterly earnings with a 5.6% increase in comparable store sales and a 12% increase in diluted EPS. The stock fell around 11% over the past month, with a 52-week low of $76.22. RSI Value is 25.3, and shares closed at $95.79 [8]

Core Insights - The energy sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, typically below 30 [1] Company Summaries - **Mach Natural Resources LP (NYSE:MNR)**: Filed for a mixed shelf of up to $250 million; stock fell approximately 12% over the past month with a 52-week low of $11.91; RSI value is 27.3; shares closed at $12.07, down 1.6% [7] - **Global Partners LP (NYSE:GLP)**: Reported weaker-than-expected Q2 results; stock declined around 14% in the last month, reaching a 52-week low of $43.20; RSI value is 25.8; shares closed at $43.89, down 2.4% [7] - **SM Energy Co (NYSE:SM)**: Analyst maintained a Sector Perform rating and raised the price target from $34 to $35; stock fell about 21% over the past month with a 52-week low of $19.67; RSI value is 29.9; shares closed at $21.79, down 1.5% [7]

Core Insights - The energy sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, typically below 30 [1] Company Summaries - **Mach Natural Resources LP (NYSE:MNR)**: Filed for a mixed shelf of up to $250 million; stock fell approximately 12% over the past month with a 52-week low of $11.91; RSI value is 27.3; shares closed at $12.07, down 1.6% [7] - **Global Partners LP (NYSE:GLP)**: Reported weaker-than-expected Q2 results; stock declined around 14% in the last month with a 52-week low of $43.20; RSI value is 25.8; shares closed at $43.89, down 2.4% [7] - **SM Energy Co (NYSE:SM)**: Analyst maintained a Sector Perform rating and raised the price target from $34 to $35; stock fell about 21% over the past month with a 52-week low of $19.67; RSI value is 29.9; shares closed at $21.79, down 1.5% [7]

Core Insights - The communication services sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Company Summaries - **Amber International Holding Ltd (NASDAQ:AMBR)**: Reported a year-over-year increase in Q2 sales, with total revenue reaching $21.0 million, driven by a record revenue of $11.5 million in wealth management. The stock has fallen approximately 44% over the past month, with an RSI of 23.5 and a closing price of $2.44 [8] - **Verizon Communications Inc (NYSE:VZ)**: Announced a commercial agreement with AST SpaceMobile for direct-to-cellular connectivity starting in 2026. The stock has decreased around 9% over the past month, with an RSI of 23.9 and a closing price of $39.75 [8] - **Criteo SA (NASDAQ:CRTO)**: Entered a multi-year partnership with DoorDash to enhance advertising opportunities. The stock has fallen about 10% over the past month, with an RSI of 25.1 and a closing price of $19.65 [8]

Core Insights - The information technology sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, with values below 30 indicating potential buying opportunities [1] Company Summaries - **Freshworks Inc (NASDAQ:FRSH)**: - Recently appointed Enrique Ortegon as senior vice president and general manager of Americas Field Sales, expected to drive growth [8] - Stock has decreased approximately 15% over the past month, with a 52-week low of $10.81 [8] - Current RSI value is 29.7, with shares closing at $11.18, reflecting a 1.2% decline [8] - **PAR Technology Corp (NYSE:PAR)**: - Analyst Mark Palmer maintained a Buy rating but reduced the price target from $92 to $77 [8] - Stock has fallen around 21% in the last month, reaching a 52-week low of $37.29 [8] - Current RSI value is 23.4, with shares closing at $37.96, showing a slight increase of 0.2% [8] - **Rapid7 Inc (NASDAQ:RPD)**: - Analyst Erin Wilson maintained an Equal-Weight rating and lowered the price target from $28 to $22 [8] - Stock has decreased about 14% over the past month, with a 52-week low of $17.76 [8] - Current RSI value is 26.3, with shares closing at $17.77, reflecting a 4.5% decline [8]

Core Insights - The health care sector is experiencing a trend of oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Group 1: Oversold Stocks - MoonLake Immunotherapeutics (NASDAQ: MLTX) has an RSI of 21.5, with a stock price drop of approximately 86% over the past month, reaching a 52-week low of $5.95. The stock saw a 13% increase to close at $8.43 [3][7] - CorVel Corp (NASDAQ: CRVL) has an RSI of 27.2, with a stock price decline of around 14% over the past month, hitting a 52-week low of $72.15. The stock rose 0.6% to close at $73.83 [4][7] - Harmony Biosciences Holdings Inc (NASDAQ: HRMY) has an RSI of 28.9, with a stock price decrease of about 24% over the past month, reaching a 52-week low of $26.26. The stock gained 2% to close at $27.28 [4][7] Group 2: Company Updates - MoonLake Immunotherapeutics reported week-16 results from its Phase 3 VELA-1 and VELA-2 trials, using HiSCR75 as the primary endpoint [7] - CorVel's CFO Brandon T. O'Brien stepped down, impacting the company's stock performance [7] - Harmony Biosciences Holdings announced topline results from its Phase 3 RECONNECT Study for ZYN002 in Fragile X syndrome, highlighting a catalyst-rich pipeline and plans for future trials [7]

Core Insights - The health care sector is experiencing a trend of oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Group 1: Oversold Stocks - MoonLake Immunotherapeutics (NASDAQ: MLTX) has an RSI of 21.5, with a stock price drop of approximately 86% over the past month, reaching a 52-week low of $5.95. Recent price action saw a 13% increase, closing at $8.43 [3][7] - CorVel Corp (NASDAQ: CRVL) has an RSI of 27.2, with a stock price decline of around 14% over the past month, hitting a 52-week low of $72.15. The stock rose 0.6% to close at $73.83 [4][7] - Harmony Biosciences Holdings Inc (NASDAQ: HRMY) has an RSI of 28.9, with a stock price decrease of about 24% over the past month, reaching a 52-week low of $26.26. The stock gained 2% to close at $27.28 [4][7] Group 2: Company Developments - MoonLake Immunotherapeutics reported week-16 results from its Phase 3 VELA-1 and VELA-2 trials, using HiSCR75 as the primary endpoint [7] - CorVel's CFO Brandon T. O'Brien stepped down, impacting the company's stock performance [7] - Harmony Biosciences released topline results from its Phase 3 RECONNECT Study for ZYN002 in Fragile X syndrome, highlighting a catalyst-rich pipeline and plans for future trials [7]

Core Insights - The financial sector is experiencing a trend of oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Group 1: Oversold Stocks - KKR & Co Inc has an RSI value of 27.2, with shares closing at $124.63 after a 2.2% decline [8] - MarketAxess Holdings Inc also has an RSI value of 27.2, with shares closing at $169.59 after a 0.7% decline [8] - Apollo Global Management has an RSI value of 29.9, with shares closing at $127.23 after a 2.1% decline [8] Group 2: Upcoming Financial Results - KKR & Co is set to release its Q3 financial results on November 7, 2025 [8] - Apollo Global Management will release its Q3 financial results on November 4, 2025 [8] Group 3: Analyst Ratings - Morgan Stanley analyst maintained an Overweight rating for MarketAxess, lowering the price target from $274 to $253 [8]

Core Insights - The financial sector is experiencing a trend of oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator used to identify oversold conditions, with a value below 30 indicating potential undervaluation [1] Company Summaries - **KKR & Co Inc (NYSE:KKR)**: - Scheduled to release Q3 financial results on Nov. 7, 2025, before market opens - Stock has decreased approximately 8% over the past five days, with a 52-week low of $86.15 - Current RSI value is 27.2, with shares closing at $124.63, down 2.2% [3][8] - **MarketAxess Holdings Inc (NASDAQ:MKTX)**: - Morgan Stanley analyst maintained an Overweight rating but reduced the price target from $274 to $253 - Stock has fallen around 5% in the last five days, with a 52-week low of $168.74 - Current RSI value is 27.2, with shares closing at $169.59, down 0.7% [4][8] - **Apollo Global Management (NYSE:APO)**: - Expected to announce Q3 financial results on Nov. 4, 2025, before market opens - Stock has decreased about 7% over the past five days, with a 52-week low of $102.58 - Current RSI value is 29.9, with shares closing at $127.23, down 2.1% [5][8]

Core Insights - The Relative Strength Index (RSI) is a key tool for technical analysts to assess stock momentum and identify overbought or oversold conditions [1] - An RSI threshold of 30 indicates potential oversold conditions, suggesting a possible trend reversal for future gains [2] Amentum Overview - Amentum (AMTM) is a defense contractor providing various services, with shares down approximately 20% over the past year despite a strong fiscal Q3 performance [3] - Revenue increased by 66% year-over-year on a GAAP basis, although it fell short of analyst expectations; the company achieved a 3-cent earnings beat and repaid $450 million in debt [4] - Six out of ten analysts rated AMTM as a Buy, with a consensus price target of $28.40, indicating over 27% upside potential from the current price [5] - Amentum's RSI is currently at 25.7, indicating oversold conditions, while short interest has risen by 14% [6] Gogo Overview - Gogo Inc. (GOGO) is a provider of in-flight wireless and entertainment services, with shares currently priced at $9.11 [7] - The company launched its Galileo HDX satcom service and is rolling out enhanced 5G services to compete with Starlink [8] - Gogo reported record equipment sales, leading to free cash flow of $62 million, but shares have fallen nearly 21% in the last month despite a 6% year-to-date increase [9] - Gogo's RSI is at 12.8, indicating oversold conditions, with short interest increasing by almost 8% [10] DoubleVerify Overview - DoubleVerify Inc. (DV) specializes in digital media data and analytics, with shares priced at $11.90 [12] - The company experienced a 21% year-over-year revenue increase and raised its revenue growth guidance from 13% to 15% for the year [13] - DoubleVerify's RSI is at 17.9, suggesting oversold conditions, while short interest has decreased by over 8% [14] - Fourteen analysts rated DV as a Buy, indicating a potential upside of about 62% [14]